ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global GnRH Agonist Market Research Report 2025
Published Date: May 2025
|
Report Code: QYRE-Auto-36K15006
Home | Market Reports | Health| Reproductive Health
Global GnRH Agonist Market Research Report 2023
BUY CHAPTERS

Global GnRH Agonist Market Research Report 2025

Code: QYRE-Auto-36K15006
Report
May 2025
Pages:94
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
Pfizer Inc
AbbVie
Astrazeneca plc
Ferring
TerSera Therapeutics
Astellas Pharma
Takeda
LIVZON
Ipsen S A
Sanofi
Endo
Tocris Bioscience
Sigma-aldrich
MedChem Express
Arbor Pharmaceuticals

GnRH Agonist Market

The global market for GnRH Agonist was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
GnRH, also known as gonadotropin-releasing hormone, is a peptide hormone secreted by the hypothalamus, which further stimulates the pituitary gland to release and synthesize gonadotropins, including follicle-stimulating hormone and luteinizing hormone. Controls the function of the ovary and the function of the testis. GnRH agonists are generally referred to as gonadotropin-releasing hormone agonists. Gonadorelin-releasing hormone agonists generally include triptorelin acetate injection, gonadorelin for injection, leuprolide acetate microspheres for injection and other drugs.
North American market for GnRH Agonist is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Asia-Pacific market for GnRH Agonist is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The major global manufacturers of GnRH Agonist include Pfizer, AbbVie, AstraZeneca, Ferring, TerSera Therapeutics, Astellas Pharma, Takeda, LIVZON, Ipsen, Sanofi, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.

Report Scope

This report aims to provide a comprehensive presentation of the global market for GnRH Agonist, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding GnRH Agonist.
The GnRH Agonist market size, estimations, and forecasts are provided in terms of sales volume (Kilogram) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global GnRH Agonist market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the GnRH Agonist manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Scope of GnRH Agonist Market Report

Report Metric Details
Report Name GnRH Agonist Market
Segment by Type
Segment by Application
  • For Human
  • For Veterinary
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company Pfizer, AbbVie, AstraZeneca, Ferring, TerSera Therapeutics, Astellas Pharma, Takeda, LIVZON, Ipsen, Sanofi, Endo, Tocris Bioscience, Sigma-Aldrich, MedChem Express, Arbor Pharmaceuticals
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Detailed analysis of GnRH Agonist manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Sales, revenue of GnRH Agonist in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 9: The main points and conclusions of the report. 

FAQ for this report

Who are the main players in the GnRH Agonist Market report?

Ans: The main players in the GnRH Agonist Market are Pfizer, AbbVie, AstraZeneca, Ferring, TerSera Therapeutics, Astellas Pharma, Takeda, LIVZON, Ipsen, Sanofi, Endo, Tocris Bioscience, Sigma-Aldrich, MedChem Express, Arbor Pharmaceuticals

What are the Application segmentation covered in the GnRH Agonist Market report?

Ans: The Applications covered in the GnRH Agonist Market report are For Human, For Veterinary

What are the Type segmentation covered in the GnRH Agonist Market report?

Ans: The Types covered in the GnRH Agonist Market report are Prostap, Zoladex, Triptorelin, Histrelin, Nafarelin, Others

Recommended Reports

GnRH Agonist Drugs

Fertility & Reproduction

GnRH & Related Market

1 GnRH Agonist Market Overview
1.1 Product Definition
1.2 GnRH Agonist by Type
1.2.1 Global GnRH Agonist Market Value Comparison by Type (2024 VS 2031)
1.2.2 Prostap
1.2.3 Zoladex
1.2.4 Triptorelin
1.2.5 Histrelin
1.2.6 Nafarelin
1.2.7 Others
1.3 GnRH Agonist by Application
1.3.1 Global GnRH Agonist Market Value by Application (2024 VS 2031)
1.3.2 For Human
1.3.3 For Veterinary
1.4 Global GnRH Agonist Market Size Estimates and Forecasts
1.4.1 Global GnRH Agonist Revenue 2020-2031
1.4.2 Global GnRH Agonist Sales 2020-2031
1.4.3 Global GnRH Agonist Market Average Price (2020-2031)
1.5 Assumptions and Limitations
2 GnRH Agonist Market Competition by Manufacturers
2.1 Global GnRH Agonist Sales Market Share by Manufacturers (2020-2025)
2.2 Global GnRH Agonist Revenue Market Share by Manufacturers (2020-2025)
2.3 Global GnRH Agonist Average Price by Manufacturers (2020-2025)
2.4 Global Key Players of GnRH Agonist, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of GnRH Agonist, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of GnRH Agonist, Product Type & Application
2.7 Global Key Manufacturers of GnRH Agonist, Date of Enter into This Industry
2.8 Global GnRH Agonist Market Competitive Situation and Trends
2.8.1 Global GnRH Agonist Market Concentration Rate
2.8.2 The Global 5 and 10 Largest GnRH Agonist Players Market Share by Revenue
2.8.3 Global GnRH Agonist Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global GnRH Agonist Market Scenario by Region
3.1 Global GnRH Agonist Market Size by Region: 2020 Versus 2024 Versus 2031
3.2 Global GnRH Agonist Sales by Region: 2020-2031
3.2.1 Global GnRH Agonist Sales by Region: 2020-2025
3.2.2 Global GnRH Agonist Sales by Region: 2026-2031
3.3 Global GnRH Agonist Revenue by Region: 2020-2031
3.3.1 Global GnRH Agonist Revenue by Region: 2020-2025
3.3.2 Global GnRH Agonist Revenue by Region: 2026-2031
3.4 North America GnRH Agonist Market Facts & Figures by Country
3.4.1 North America GnRH Agonist Market Size by Country: 2020 VS 2024 VS 2031
3.4.2 North America GnRH Agonist Sales by Country (2020-2031)
3.4.3 North America GnRH Agonist Revenue by Country (2020-2031)
3.4.4 United States
3.4.5 Canada
3.5 Europe GnRH Agonist Market Facts & Figures by Country
3.5.1 Europe GnRH Agonist Market Size by Country: 2020 VS 2024 VS 2031
3.5.2 Europe GnRH Agonist Sales by Country (2020-2031)
3.5.3 Europe GnRH Agonist Revenue by Country (2020-2031)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific GnRH Agonist Market Facts & Figures by Region
3.6.1 Asia Pacific GnRH Agonist Market Size by Region: 2020 VS 2024 VS 2031
3.6.2 Asia Pacific GnRH Agonist Sales by Region (2020-2031)
3.6.3 Asia Pacific GnRH Agonist Revenue by Region (2020-2031)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America GnRH Agonist Market Facts & Figures by Country
3.7.1 Latin America GnRH Agonist Market Size by Country: 2020 VS 2024 VS 2031
3.7.2 Latin America GnRH Agonist Sales by Country (2020-2031)
3.7.3 Latin America GnRH Agonist Revenue by Country (2020-2031)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa GnRH Agonist Market Facts & Figures by Country
3.8.1 Middle East and Africa GnRH Agonist Market Size by Country: 2020 VS 2024 VS 2031
3.8.2 Middle East and Africa GnRH Agonist Sales by Country (2020-2031)
3.8.3 Middle East and Africa GnRH Agonist Revenue by Country (2020-2031)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global GnRH Agonist Sales by Type (2020-2031)
4.1.1 Global GnRH Agonist Sales by Type (2020-2025)
4.1.2 Global GnRH Agonist Sales by Type (2026-2031)
4.1.3 Global GnRH Agonist Sales Market Share by Type (2020-2031)
4.2 Global GnRH Agonist Revenue by Type (2020-2031)
4.2.1 Global GnRH Agonist Revenue by Type (2020-2025)
4.2.2 Global GnRH Agonist Revenue by Type (2026-2031)
4.2.3 Global GnRH Agonist Revenue Market Share by Type (2020-2031)
4.3 Global GnRH Agonist Price by Type (2020-2031)
5 Segment by Application
5.1 Global GnRH Agonist Sales by Application (2020-2031)
5.1.1 Global GnRH Agonist Sales by Application (2020-2025)
5.1.2 Global GnRH Agonist Sales by Application (2026-2031)
5.1.3 Global GnRH Agonist Sales Market Share by Application (2020-2031)
5.2 Global GnRH Agonist Revenue by Application (2020-2031)
5.2.1 Global GnRH Agonist Revenue by Application (2020-2025)
5.2.2 Global GnRH Agonist Revenue by Application (2026-2031)
5.2.3 Global GnRH Agonist Revenue Market Share by Application (2020-2031)
5.3 Global GnRH Agonist Price by Application (2020-2031)
6 Key Companies Profiled
6.1 Pfizer
6.1.1 Pfizer Company Information
6.1.2 Pfizer Description and Business Overview
6.1.3 Pfizer GnRH Agonist Sales, Revenue and Gross Margin (2020-2025)
6.1.4 Pfizer GnRH Agonist Product Portfolio
6.1.5 Pfizer Recent Developments/Updates
6.2 AbbVie
6.2.1 AbbVie Company Information
6.2.2 AbbVie Description and Business Overview
6.2.3 AbbVie GnRH Agonist Sales, Revenue and Gross Margin (2020-2025)
6.2.4 AbbVie GnRH Agonist Product Portfolio
6.2.5 AbbVie Recent Developments/Updates
6.3 AstraZeneca
6.3.1 AstraZeneca Company Information
6.3.2 AstraZeneca Description and Business Overview
6.3.3 AstraZeneca GnRH Agonist Sales, Revenue and Gross Margin (2020-2025)
6.3.4 AstraZeneca GnRH Agonist Product Portfolio
6.3.5 AstraZeneca Recent Developments/Updates
6.4 Ferring
6.4.1 Ferring Company Information
6.4.2 Ferring Description and Business Overview
6.4.3 Ferring GnRH Agonist Sales, Revenue and Gross Margin (2020-2025)
6.4.4 Ferring GnRH Agonist Product Portfolio
6.4.5 Ferring Recent Developments/Updates
6.5 TerSera Therapeutics
6.5.1 TerSera Therapeutics Company Information
6.5.2 TerSera Therapeutics Description and Business Overview
6.5.3 TerSera Therapeutics GnRH Agonist Sales, Revenue and Gross Margin (2020-2025)
6.5.4 TerSera Therapeutics GnRH Agonist Product Portfolio
6.5.5 TerSera Therapeutics Recent Developments/Updates
6.6 Astellas Pharma
6.6.1 Astellas Pharma Company Information
6.6.2 Astellas Pharma Description and Business Overview
6.6.3 Astellas Pharma GnRH Agonist Sales, Revenue and Gross Margin (2020-2025)
6.6.4 Astellas Pharma GnRH Agonist Product Portfolio
6.6.5 Astellas Pharma Recent Developments/Updates
6.7 Takeda
6.7.1 Takeda Company Information
6.7.2 Takeda Description and Business Overview
6.7.3 Takeda GnRH Agonist Sales, Revenue and Gross Margin (2020-2025)
6.7.4 Takeda GnRH Agonist Product Portfolio
6.7.5 Takeda Recent Developments/Updates
6.8 LIVZON
6.8.1 LIVZON Company Information
6.8.2 LIVZON Description and Business Overview
6.8.3 LIVZON GnRH Agonist Sales, Revenue and Gross Margin (2020-2025)
6.8.4 LIVZON GnRH Agonist Product Portfolio
6.8.5 LIVZON Recent Developments/Updates
6.9 Ipsen
6.9.1 Ipsen Company Information
6.9.2 Ipsen Description and Business Overview
6.9.3 Ipsen GnRH Agonist Sales, Revenue and Gross Margin (2020-2025)
6.9.4 Ipsen GnRH Agonist Product Portfolio
6.9.5 Ipsen Recent Developments/Updates
6.10 Sanofi
6.10.1 Sanofi Company Information
6.10.2 Sanofi Description and Business Overview
6.10.3 Sanofi GnRH Agonist Sales, Revenue and Gross Margin (2020-2025)
6.10.4 Sanofi GnRH Agonist Product Portfolio
6.10.5 Sanofi Recent Developments/Updates
6.11 Endo
6.11.1 Endo Company Information
6.11.2 Endo Description and Business Overview
6.11.3 Endo GnRH Agonist Sales, Revenue and Gross Margin (2020-2025)
6.11.4 Endo GnRH Agonist Product Portfolio
6.11.5 Endo Recent Developments/Updates
6.12 Tocris Bioscience
6.12.1 Tocris Bioscience Company Information
6.12.2 Tocris Bioscience Description and Business Overview
6.12.3 Tocris Bioscience GnRH Agonist Sales, Revenue and Gross Margin (2020-2025)
6.12.4 Tocris Bioscience GnRH Agonist Product Portfolio
6.12.5 Tocris Bioscience Recent Developments/Updates
6.13 Sigma-Aldrich
6.13.1 Sigma-Aldrich Company Information
6.13.2 Sigma-Aldrich Description and Business Overview
6.13.3 Sigma-Aldrich GnRH Agonist Sales, Revenue and Gross Margin (2020-2025)
6.13.4 Sigma-Aldrich GnRH Agonist Product Portfolio
6.13.5 Sigma-Aldrich Recent Developments/Updates
6.14 MedChem Express
6.14.1 MedChem Express Company Information
6.14.2 MedChem Express Description and Business Overview
6.14.3 MedChem Express GnRH Agonist Sales, Revenue and Gross Margin (2020-2025)
6.14.4 MedChem Express GnRH Agonist Product Portfolio
6.14.5 MedChem Express Recent Developments/Updates
6.15 Arbor Pharmaceuticals
6.15.1 Arbor Pharmaceuticals Company Information
6.15.2 Arbor Pharmaceuticals Description and Business Overview
6.15.3 Arbor Pharmaceuticals GnRH Agonist Sales, Revenue and Gross Margin (2020-2025)
6.15.4 Arbor Pharmaceuticals GnRH Agonist Product Portfolio
6.15.5 Arbor Pharmaceuticals Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 GnRH Agonist Industry Chain Analysis
7.2 GnRH Agonist Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 GnRH Agonist Production Mode & Process Analysis
7.4 GnRH Agonist Sales and Marketing
7.4.1 GnRH Agonist Sales Channels
7.4.2 GnRH Agonist Distributors
7.5 GnRH Agonist Customer Analysis
8 GnRH Agonist Market Dynamics
8.1 GnRH Agonist Industry Trends
8.2 GnRH Agonist Market Drivers
8.3 GnRH Agonist Market Challenges
8.4 GnRH Agonist Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
FEATURED COMPANIES
Pfizer Inc
AbbVie
Astrazeneca plc
Ferring
TerSera Therapeutics
Astellas Pharma
Takeda
LIVZON
Ipsen S A
Sanofi
Endo
Tocris Bioscience
Sigma-aldrich
MedChem Express
Arbor Pharmaceuticals
List of Tables
 Table 1. Global GnRH Agonist Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
 Table 2. Global GnRH Agonist Market Value by Application (2024 VS 2031) & (US$ Million)
 Table 3. Global GnRH Agonist Market Competitive Situation by Manufacturers in 2024
 Table 4. Global GnRH Agonist Sales (Kilogram) of Key Manufacturers (2020-2025)
 Table 5. Global GnRH Agonist Sales Market Share by Manufacturers (2020-2025)
 Table 6. Global GnRH Agonist Revenue (US$ Million) by Manufacturers (2020-2025)
 Table 7. Global GnRH Agonist Revenue Share by Manufacturers (2020-2025)
 Table 8. Global Market GnRH Agonist Average Price (US$/mg) of Key Manufacturers (2020-2025)
 Table 9. Global Key Players of GnRH Agonist, Industry Ranking, 2022 VS 2023 VS 2024
 Table 10. Global Key Manufacturers of GnRH Agonist, Manufacturing Sites & Headquarters
 Table 11. Global Key Manufacturers of GnRH Agonist, Product Type & Application
 Table 12. Global Key Manufacturers of GnRH Agonist, Date of Enter into This Industry
 Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
 Table 14. Global GnRH Agonist by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in GnRH Agonist as of 2024)
 Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
 Table 16. Global GnRH Agonist Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 17. Global GnRH Agonist Sales by Region (2020-2025) & (Kilogram)
 Table 18. Global GnRH Agonist Sales Market Share by Region (2020-2025)
 Table 19. Global GnRH Agonist Sales by Region (2026-2031) & (Kilogram)
 Table 20. Global GnRH Agonist Sales Market Share by Region (2026-2031)
 Table 21. Global GnRH Agonist Revenue by Region (2020-2025) & (US$ Million)
 Table 22. Global GnRH Agonist Revenue Market Share by Region (2020-2025)
 Table 23. Global GnRH Agonist Revenue by Region (2026-2031) & (US$ Million)
 Table 24. Global GnRH Agonist Revenue Market Share by Region (2026-2031)
 Table 25. North America GnRH Agonist Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 26. North America GnRH Agonist Sales by Country (2020-2025) & (Kilogram)
 Table 27. North America GnRH Agonist Sales by Country (2026-2031) & (Kilogram)
 Table 28. North America GnRH Agonist Revenue by Country (2020-2025) & (US$ Million)
 Table 29. North America GnRH Agonist Revenue by Country (2026-2031) & (US$ Million)
 Table 30. Europe GnRH Agonist Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 31. Europe GnRH Agonist Sales by Country (2020-2025) & (Kilogram)
 Table 32. Europe GnRH Agonist Sales by Country (2026-2031) & (Kilogram)
 Table 33. Europe GnRH Agonist Revenue by Country (2020-2025) & (US$ Million)
 Table 34. Europe GnRH Agonist Revenue by Country (2026-2031) & (US$ Million)
 Table 35. Asia Pacific GnRH Agonist Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 36. Asia Pacific GnRH Agonist Sales by Region (2020-2025) & (Kilogram)
 Table 37. Asia Pacific GnRH Agonist Sales by Region (2026-2031) & (Kilogram)
 Table 38. Asia Pacific GnRH Agonist Revenue by Region (2020-2025) & (US$ Million)
 Table 39. Asia Pacific GnRH Agonist Revenue by Region (2026-2031) & (US$ Million)
 Table 40. Latin America GnRH Agonist Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 41. Latin America GnRH Agonist Sales by Country (2020-2025) & (Kilogram)
 Table 42. Latin America GnRH Agonist Sales by Country (2026-2031) & (Kilogram)
 Table 43. Latin America GnRH Agonist Revenue by Country (2020-2025) & (US$ Million)
 Table 44. Latin America GnRH Agonist Revenue by Country (2026-2031) & (US$ Million)
 Table 45. Middle East and Africa GnRH Agonist Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 46. Middle East and Africa GnRH Agonist Sales by Country (2020-2025) & (Kilogram)
 Table 47. Middle East and Africa GnRH Agonist Sales by Country (2026-2031) & (Kilogram)
 Table 48. Middle East and Africa GnRH Agonist Revenue by Country (2020-2025) & (US$ Million)
 Table 49. Middle East and Africa GnRH Agonist Revenue by Country (2026-2031) & (US$ Million)
 Table 50. Global GnRH Agonist Sales (Kilogram) by Type (2020-2025)
 Table 51. Global GnRH Agonist Sales (Kilogram) by Type (2026-2031)
 Table 52. Global GnRH Agonist Sales Market Share by Type (2020-2025)
 Table 53. Global GnRH Agonist Sales Market Share by Type (2026-2031)
 Table 54. Global GnRH Agonist Revenue (US$ Million) by Type (2020-2025)
 Table 55. Global GnRH Agonist Revenue (US$ Million) by Type (2026-2031)
 Table 56. Global GnRH Agonist Revenue Market Share by Type (2020-2025)
 Table 57. Global GnRH Agonist Revenue Market Share by Type (2026-2031)
 Table 58. Global GnRH Agonist Price (US$/mg) by Type (2020-2025)
 Table 59. Global GnRH Agonist Price (US$/mg) by Type (2026-2031)
 Table 60. Global GnRH Agonist Sales (Kilogram) by Application (2020-2025)
 Table 61. Global GnRH Agonist Sales (Kilogram) by Application (2026-2031)
 Table 62. Global GnRH Agonist Sales Market Share by Application (2020-2025)
 Table 63. Global GnRH Agonist Sales Market Share by Application (2026-2031)
 Table 64. Global GnRH Agonist Revenue (US$ Million) by Application (2020-2025)
 Table 65. Global GnRH Agonist Revenue (US$ Million) by Application (2026-2031)
 Table 66. Global GnRH Agonist Revenue Market Share by Application (2020-2025)
 Table 67. Global GnRH Agonist Revenue Market Share by Application (2026-2031)
 Table 68. Global GnRH Agonist Price (US$/mg) by Application (2020-2025)
 Table 69. Global GnRH Agonist Price (US$/mg) by Application (2026-2031)
 Table 70. Pfizer Company Information
 Table 71. Pfizer Description and Business Overview
 Table 72. Pfizer GnRH Agonist Sales (Kilogram), Revenue (US$ Million), Price (US$/mg) and Gross Margin (2020-2025)
 Table 73. Pfizer GnRH Agonist Product
 Table 74. Pfizer Recent Developments/Updates
 Table 75. AbbVie Company Information
 Table 76. AbbVie Description and Business Overview
 Table 77. AbbVie GnRH Agonist Sales (Kilogram), Revenue (US$ Million), Price (US$/mg) and Gross Margin (2020-2025)
 Table 78. AbbVie GnRH Agonist Product
 Table 79. AbbVie Recent Developments/Updates
 Table 80. AstraZeneca Company Information
 Table 81. AstraZeneca Description and Business Overview
 Table 82. AstraZeneca GnRH Agonist Sales (Kilogram), Revenue (US$ Million), Price (US$/mg) and Gross Margin (2020-2025)
 Table 83. AstraZeneca GnRH Agonist Product
 Table 84. AstraZeneca Recent Developments/Updates
 Table 85. Ferring Company Information
 Table 86. Ferring Description and Business Overview
 Table 87. Ferring GnRH Agonist Sales (Kilogram), Revenue (US$ Million), Price (US$/mg) and Gross Margin (2020-2025)
 Table 88. Ferring GnRH Agonist Product
 Table 89. Ferring Recent Developments/Updates
 Table 90. TerSera Therapeutics Company Information
 Table 91. TerSera Therapeutics Description and Business Overview
 Table 92. TerSera Therapeutics GnRH Agonist Sales (Kilogram), Revenue (US$ Million), Price (US$/mg) and Gross Margin (2020-2025)
 Table 93. TerSera Therapeutics GnRH Agonist Product
 Table 94. TerSera Therapeutics Recent Developments/Updates
 Table 95. Astellas Pharma Company Information
 Table 96. Astellas Pharma Description and Business Overview
 Table 97. Astellas Pharma GnRH Agonist Sales (Kilogram), Revenue (US$ Million), Price (US$/mg) and Gross Margin (2020-2025)
 Table 98. Astellas Pharma GnRH Agonist Product
 Table 99. Astellas Pharma Recent Developments/Updates
 Table 100. Takeda Company Information
 Table 101. Takeda Description and Business Overview
 Table 102. Takeda GnRH Agonist Sales (Kilogram), Revenue (US$ Million), Price (US$/mg) and Gross Margin (2020-2025)
 Table 103. Takeda GnRH Agonist Product
 Table 104. Takeda Recent Developments/Updates
 Table 105. LIVZON Company Information
 Table 106. LIVZON Description and Business Overview
 Table 107. LIVZON GnRH Agonist Sales (Kilogram), Revenue (US$ Million), Price (US$/mg) and Gross Margin (2020-2025)
 Table 108. LIVZON GnRH Agonist Product
 Table 109. LIVZON Recent Developments/Updates
 Table 110. Ipsen Company Information
 Table 111. Ipsen Description and Business Overview
 Table 112. Ipsen GnRH Agonist Sales (Kilogram), Revenue (US$ Million), Price (US$/mg) and Gross Margin (2020-2025)
 Table 113. Ipsen GnRH Agonist Product
 Table 114. Ipsen Recent Developments/Updates
 Table 115. Sanofi Company Information
 Table 116. Sanofi Description and Business Overview
 Table 117. Sanofi GnRH Agonist Sales (Kilogram), Revenue (US$ Million), Price (US$/mg) and Gross Margin (2020-2025)
 Table 118. Sanofi GnRH Agonist Product
 Table 119. Sanofi Recent Developments/Updates
 Table 120. Endo Company Information
 Table 121. Endo Description and Business Overview
 Table 122. Endo GnRH Agonist Sales (Kilogram), Revenue (US$ Million), Price (US$/mg) and Gross Margin (2020-2025)
 Table 123. Endo GnRH Agonist Product
 Table 124. Endo Recent Developments/Updates
 Table 125. Tocris Bioscience Company Information
 Table 126. Tocris Bioscience Description and Business Overview
 Table 127. Tocris Bioscience GnRH Agonist Sales (Kilogram), Revenue (US$ Million), Price (US$/mg) and Gross Margin (2020-2025)
 Table 128. Tocris Bioscience GnRH Agonist Product
 Table 129. Tocris Bioscience Recent Developments/Updates
 Table 130. Sigma-Aldrich Company Information
 Table 131. Sigma-Aldrich Description and Business Overview
 Table 132. Sigma-Aldrich GnRH Agonist Sales (Kilogram), Revenue (US$ Million), Price (US$/mg) and Gross Margin (2020-2025)
 Table 133. Sigma-Aldrich GnRH Agonist Product
 Table 134. Sigma-Aldrich Recent Developments/Updates
 Table 135. MedChem Express Company Information
 Table 136. MedChem Express Description and Business Overview
 Table 137. MedChem Express GnRH Agonist Sales (Kilogram), Revenue (US$ Million), Price (US$/mg) and Gross Margin (2020-2025)
 Table 138. MedChem Express GnRH Agonist Product
 Table 139. MedChem Express Recent Developments/Updates
 Table 140. Arbor Pharmaceuticals Company Information
 Table 141. Arbor Pharmaceuticals Description and Business Overview
 Table 142. Arbor Pharmaceuticals GnRH Agonist Sales (Kilogram), Revenue (US$ Million), Price (US$/mg) and Gross Margin (2020-2025)
 Table 143. Arbor Pharmaceuticals GnRH Agonist Product
 Table 144. Arbor Pharmaceuticals Recent Developments/Updates
 Table 145. Key Raw Materials Lists
 Table 146. Raw Materials Key Suppliers Lists
 Table 147. GnRH Agonist Distributors List
 Table 148. GnRH Agonist Customers List
 Table 149. GnRH Agonist Market Trends
 Table 150. GnRH Agonist Market Drivers
 Table 151. GnRH Agonist Market Challenges
 Table 152. GnRH Agonist Market Restraints
 Table 153. Research Programs/Design for This Report
 Table 154. Key Data Information from Secondary Sources
 Table 155. Key Data Information from Primary Sources
 Table 156. Authors List of This Report


List of Figures
 Figure 1. Product Picture of GnRH Agonist
 Figure 2. Global GnRH Agonist Market Value Comparison by Type (2020-2031) & (US$ Million)
 Figure 3. Global GnRH Agonist Market Share by Type: 2024 & 2031
 Figure 4. Prostap Product Picture
 Figure 5. Zoladex Product Picture
 Figure 6. Triptorelin Product Picture
 Figure 7. Histrelin Product Picture
 Figure 8. Nafarelin Product Picture
 Figure 9. Others Product Picture
 Figure 10. Global GnRH Agonist Market Value by Application (2020-2031) & (US$ Million)
 Figure 11. Global GnRH Agonist Market Share by Application: 2024 & 2031
 Figure 12. For Human
 Figure 13. For Veterinary
 Figure 14. Global GnRH Agonist Revenue, (US$ Million), 2020 VS 2024 VS 2031
 Figure 15. Global GnRH Agonist Market Size (2020-2031) & (US$ Million)
 Figure 16. Global GnRH Agonist Sales (2020-2031) & (Kilogram)
 Figure 17. Global GnRH Agonist Average Price (US$/mg) & (2020-2031)
 Figure 18. GnRH Agonist Report Years Considered
 Figure 19. GnRH Agonist Sales Share by Manufacturers in 2024
 Figure 20. Global GnRH Agonist Revenue Share by Manufacturers in 2024
 Figure 21. Global 5 and 10 Largest GnRH Agonist Players: Market Share by Revenue in GnRH Agonist in 2024
 Figure 22. GnRH Agonist Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
 Figure 23. Global GnRH Agonist Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Figure 24. North America GnRH Agonist Sales Market Share by Country (2020-2031)
 Figure 25. North America GnRH Agonist Revenue Market Share by Country (2020-2031)
 Figure 26. United States GnRH Agonist Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 27. Canada GnRH Agonist Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 28. Europe GnRH Agonist Sales Market Share by Country (2020-2031)
 Figure 29. Europe GnRH Agonist Revenue Market Share by Country (2020-2031)
 Figure 30. Germany GnRH Agonist Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 31. France GnRH Agonist Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 32. U.K. GnRH Agonist Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 33. Italy GnRH Agonist Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 34. Russia GnRH Agonist Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 35. Asia Pacific GnRH Agonist Sales Market Share by Region (2020-2031)
 Figure 36. Asia Pacific GnRH Agonist Revenue Market Share by Region (2020-2031)
 Figure 37. China GnRH Agonist Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 38. Japan GnRH Agonist Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 39. South Korea GnRH Agonist Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 40. India GnRH Agonist Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 41. Australia GnRH Agonist Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 42. China Taiwan GnRH Agonist Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 43. Southeast Asia GnRH Agonist Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 44. Latin America GnRH Agonist Sales Market Share by Country (2020-2031)
 Figure 45. Latin America GnRH Agonist Revenue Market Share by Country (2020-2031)
 Figure 46. Mexico GnRH Agonist Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 47. Brazil GnRH Agonist Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 48. Argentina GnRH Agonist Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 49. Middle East and Africa GnRH Agonist Sales Market Share by Country (2020-2031)
 Figure 50. Middle East and Africa GnRH Agonist Revenue Market Share by Country (2020-2031)
 Figure 51. Turkey GnRH Agonist Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 52. Saudi Arabia GnRH Agonist Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 53. UAE GnRH Agonist Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 54. Global Sales Market Share of GnRH Agonist by Type (2020-2031)
 Figure 55. Global Revenue Market Share of GnRH Agonist by Type (2020-2031)
 Figure 56. Global GnRH Agonist Price (US$/mg) by Type (2020-2031)
 Figure 57. Global Sales Market Share of GnRH Agonist by Application (2020-2031)
 Figure 58. Global Revenue Market Share of GnRH Agonist by Application (2020-2031)
 Figure 59. Global GnRH Agonist Price (US$/mg) by Application (2020-2031)
 Figure 60. GnRH Agonist Value Chain
 Figure 61. Channels of Distribution (Direct Vs Distribution)
 Figure 62. Bottom-up and Top-down Approaches for This Report
 Figure 63. Data Triangulation
 Figure 64. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Accenture

SIMILAR REPORTS

Gonadotropin releasing Hormone Agonist Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Gonadotropin releasing Hormone Agonist Drugs Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Gonadorelin Market Insights Forecast to 2030
Global Gonadorelin Acetate Market Insights Forecast to 2030
Luteinizing Hormone releasing Hormone Analogs Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Luteinizing Hormone releasing Hormone Analogs Drugs Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global GnRH Receptor Antagonists Market Research Report 2024
Global GnRH Analogues Market Research Report 2024
Global Leuprorelin Drugs Market Research Report 2024
Global GnRH Pulse Pump Market Research Report 2024
Global Triptorelin Acetate Microspheres for Injection Market Research Report 2024
Global Gonadotropin releasing Hormone Antagonists Market Research Report 2024
Global GnRHa Peptide Drugs Market Research Report 2024
Global Pituitary Hormone Pump Market Research Report 2024
Global Leuprorelin Acetate Microspheres for Injection Market Research Report 2024
Global Alarelin Acetate Market Insights Forecast to 2030
Global Oral GnRH Drugs Market Research Report 2024
Global Leuprorelin Acetate Market Insights Forecast to 2030
Global Non injectable GnRH Drugs Market Research Report 2024
Global Buserelin Market Research Report 2024

RELATED REPORTS

Global Foetal Skull Model Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-8G20187
Fri Nov 28 00:00:00 UTC 2025

Add to Cart

Global Anatomy Set Pregnancy Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-30J19782
Sat Nov 22 00:00:00 UTC 2025

Add to Cart

Global Embryo Model Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-39D19945
Sat Nov 22 00:00:00 UTC 2025

Add to Cart

Global Prostate Model Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-25M19897
Sat Nov 22 00:00:00 UTC 2025

Add to Cart

Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions